Groningen

• Multicenter phase 1b/II trial testing neoadjuvant intradermal Ipilimumab and Nivolumab in high risk stage II melanoma –MARIANE Recruiting
  2023-505945-19-00 4 2024-03-08 stage II melanoma
• A Study of Repotrectinib versus Crizotinib in Participants with Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-po … Recruiting
  2023-505604-32-00 5 2024-01-24 Non small cell lung cancer (NSCLC)
• Ulcerative Colitis: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Moderately to Severely Active Ulcerati … Recruiting
  2022-501788-41-00 5 2023-11-14 Ulcerative Colitis
• A Study of Ripretinib vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumor (GIST) with Specific KIT Exon Mutations Who Were … Recruiting
  2022-503058-37-00 5 2023-11-10 Advanced Gastrointestinal Stromal Tumor
• A study to learn how safe the study treatment actinium-225-macropa-pelgifatamab (BAY3546828) is, how it affects the body, how it moves into, … Recruiting
  2022-502623-22-00 1 2023-09-18 Metastatic castration-resistant prostate cancer
• A Phase 3 program evaluating the effect of filgotinib in subjects with active axial spondyloarthritis Recruiting
  2022-501354-10-01 5 2023-06-21 axial spondyloarthritis
• Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting
  2022-500266-10-00 5 2023-06-13 Recessive Dystrophic Epidermolysis Bullosa(RDEB) and Junctional Epider
• A Phase 3 Study of Obexelimab in Patients with IgG4-Related Disease Recruiting
  2022-500718-24-00 5 2023-06-09 IgG4-Related Disease
• A Phase 3b study to learn more about the safety and tolerability of ivosidenib in combination with azacitidine in adult patients newly diagn … Recruiting
  2022-501709-11-00 5 2023-06-06 Isocitrate deshydrogenase1 mutation-positive (IDH1m) acute myeloid leu
• (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis Recruiting
  2022-501427-24-00 4 2023-04-25 Nonadvanced Systemic Mastocytosis
• This study is to find out the safety and effectiveness of Epcoritamab together with R-CHOP (rituximab, cyclophosphamide, doxorubicin HCL, vi … Recruiting
  2023-505277-32-00 5 2023-01-26 Diffuse Large B-Cell Lymphoma (DLBCL)
• Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels (ADAPT ALEC) Recruiting
  2023-506886-76-00 6 2022-03-23 ALK positive non-small cell lung cancer
• CeRebrUm and CardIac protection with ALlopurinol in Neonates with Critical Congenital Heart Disease requiring Cardiac Surgery with Cardiopul … Recruiting
  2024-513041-37-00 5 2020-02-14 Brain injury in neonates with critical congenital heart disease requir
• A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers Recruiting
  2024-517746-34-00 1 2026-06-26 Advanced breast cancer and advanced NSCLC
• PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer Recruiting
  2025-522883-34-00 6 2026-06-12 Metastatic cervical cancer
• Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184 Recruiting
  2026-525590-40-00 3 2026-06-03 human immunodeficiency virus (HIV)
• A PHASE 1, OPEN-LABEL STUDY TO ASSESS THE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION, INCLUDING THE MASS BALANCE, OF A SINGLE ORAL … Recruiting
  2025-524832-20-00 3 2026-06-01 Healthy volunteers
• A Phase 3 Study Comparing JNJ-79635322 and an anti-BCMAxCD3 Bispecific Antibody in Participants with Relapsed or Refractory Multiple Myeloma Recruiting
  2025-522007-18-00 5 2026-05-27 Relapsed or Refractory Multiple Myeloma
• PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f … Recruiting
  2023-506194-35-00 5 2026-05-22 Colorectal liver metastases
• A study to assess the safety, and blood levels of CTX-187 after single and repeated intravenous doses in healthy volunteers and patients wit … Recruiting
  2026-525619-15-00 1 2026-05-22 Bacterial Infection
• Multiple Dose Study of RO7795068 and its effect on Gastric Emptying, and on PK of Oral Contraceptives Recruiting
  2025-524052-58-00 3 2026-05-21 Healthy Overweight or Obese
• A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167 Recruiting
  2026-526096-31-00 3 2026-05-20 Chronic Heart Failure
• Dual wavelength fluorescence imaging using fluorescently labelled adalimumab and risankizumab for visualizing drug targeting in Inflammatory … Recruiting
  2025-521420-30-00 9 2026-05-08 Inflammatory Bowel Disease (IBD)
• Dual-Wavelength Quantitative Fluorescence Endoscopy for Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer: A Phase I Mult … Recruiting
  2024-520090-12-00 1 2026-05-01 Esophageal cancer

Showing 97–120 of 689 trials